← Eichor
Study identifier: NCT07191743 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Functional Assessment in Critically Ill Patients

Condition: Intensive Care Unit Acquired Weakness · Intensive Care Unit (ICU) Acquired Weakness (ICU - AW)  ·  Sponsor: Universidade Federal do Rio de Janeiro

PhaseN/A
Planned participants186
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This longitudinal, prospective observational study aims to evaluate functional status in critically ill adult patients in the Intensive Care Unit using the Chelsea Critical Care Physical Assessment Tool (CPAx). The primary objective is to analyze CPAx score variation as a potential predictor of clinical outcomes, including mortality and duration of mechanical ventilation. Functional assessments will be performed at intensive care unit (ICU) admission and discharge to monitor changes in physical function and to predict adverse clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

RAFAELA S PAIM  ·  +5521988919158  ·  rafaeladspaim@gmail.com

GABRIEL G MAIA, PhD  ·  +5521996267494  ·  gmaiafisio@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Pedro Ernesto University HospitalRio de Janeiro, Rio de Janeiro, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07191743